26 J Control Release. 2014 Sep 10;189:169-86. doi: 10.1016/j.jconrel.2014.06.020. Epub 2014 Jun 23.【摘要】
Eradication of Helicobacter pylori: Past, present and future.
幽门螺杆菌根除治疗：昨天，今天，明天
Lopes D1, Nunes C1, Martins MC2, Sarmento B3, Reis S4.
27 J Med Microbiol. 2014 Sep;63(Pt 9):1189-96. doi: 10.1099/jmm.0.075275-0. Epub 2014 Jun 25.【摘要】
Virulence genes of Helicobacter pylori in the Dominican Republic.
多米尼加共和国幽门螺杆菌毒力基因分析：cagA阳性幽门螺杆菌感染患者胃黏膜炎症更重，更容易出现萎缩
Shiota S1, Cruz M2, Abreu JA3, Mitsui T1, Terao H4, Disla M5, Iwatani S6, Nagashima H6, Matsuda M1, Uchida T7, Tronilo L3, Rodríguez E3, Yamaoka Y8.
28Scand J Gastroenterol. 2014Sep;49(9):1058-67. doi: 10.3109/00365521.2014.894117. Epub 2014 Jun 24.【摘要】
GenoType HelicoDR test in the determination of antimicrobial resistance of Helicobacter pylori in Korea.
韩国幽门螺杆菌抗生素耐药基因型测定：能够检测克拉霉素和氟喹诺酮类药物耐药基因突变，然而以MIC检测为金标准，抗生素耐药基因型测定预测耐药的敏感性和特异性欠佳
Lee JW1, Kim N, Nam RH, Park JH, Choi YJ, Kim JM, Kim JS, Jung HC.
29Gut. 2014 Sep;63(9):1526-7. doi: 10.1136/gutjnl-2014-307389. Epub 2014 Jun 20.【摘要】
Helicobacter pylori infection in gastric extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT) lymphoma: a re-evaluation.
胃黏膜相关淋巴样组织结外边缘区淋巴瘤幽门螺杆菌感染再评价
Sena Teixeira Mendes L, D Attygalle A, C Wotherspoon A.
30 Anal Bioanal Chem. 2014 Sep;406(22):5405-12. doi: 10.1007/s00216-014-7951-0. Epub 2014 Jun 18.【摘要】
Excretion kinetics of 13C-urea breath test: influences of endogenous CO2 production and dose recovery on the diagnostic accuracy of Helicobacter pylori infection.
13C尿素呼气试验排泄动力学：内源性CO2对 幽门螺杆菌感染的诊断准确性的影响 。
Som S1, Maity A, Banik GD, Ghosh C, Chaudhuri S, Daschakraborty SB, Ghosh S, Pradhan M.
31 J Bacteriol. 2014 Sep;196(17):3074-81. doi: 10.1128/JB.01423-13. Epub 2014 Jun 16.【摘要】
Ammonium metabolism enzymes aid Helicobacter pylori acid resistance.
胺代谢酶增强幽门螺杆菌酸耐受
Miller EF1, Maier RJ2.
32 Arch Oral Biol. 2014 Sep;59(9):938-43. doi: 10.1016/j.archoralbio.2014.05.020. Epub 2014 May 24.【摘要】
Relationship between oral problems and Helicobacter pylori infection.
口腔疾病与幽门螺杆菌感染
研究表明幽门螺杆菌感染与很多口腔疾病相关，尤其是牙结石和牙齿松动，可能是因为牙菌斑
Zheng Y1, Liu M2, Shu H2, Chen Z3, Liu G3, Zhang Y3.
33 Carbohydr Polym. 2014 Sep 22;110:231-7. doi: 10.1016/j.carbpol.2014.03.081. Epub 2014 Apr 2.【摘要】
Preparation, characterization, and anti-Helicobacter pylori activity of Bi3+-Hericium erinaceus polysaccharide complex.
铋剂猴头菌多糖复合物（BiHEP）的制备、特点和抗幽门螺杆菌活性，与胶体次枸橼酸铋相比，铋的含量低，而具有很好的抑菌能力
Zhu Y1, Chen Y2, Li Q3, Zhao T1, Zhang M1, Feng W3, Takase M1, Wu X1, Zhou Z1, Yang L4, Wu X5.
34World J Microbiol Biotechnol. 2014 Sep;30(9):2481-90. doi: 10.1007/s11274-014-1673-5. Epub 2014 May 23.【摘要】
Clinical relevance of cagL gene and virulence genotypes with disease outcomes in a Helicobacter pylori infected population from Iran.
伊朗人群幽门螺杆菌cagL基因及基因型与疾病预后的临床相关性，cagL与cagA的阳性呈正相关，但是研究结果提示无论是单基因型，还是组合基因型都不能预测疾病的严重性
Yadegar A1, Mobarez AM, Alebouyeh M, Mirzaei T, Kwok T, Zali MR.
35Clin Exp Immunol. 2014 Sep;177(3):598-602. doi: 10.1111/cei.12363.【摘要】
ATP4A autoimmunity and Helicobacter pylori infection in children with type 1 diabetes.
1型糖尿病儿童ATP4A自身免疫性疾病和幽门螺杆菌感染：
ATP4A自身抗体长期存在时直接针对壁细胞，是一种典型的萎缩性胃体炎，与1型糖尿病相关，然而ATP4A自身抗体的存在与幽门螺杆菌感染状态无关。
Chobot A1, Wenzlau J, Bak-Drabik K, Kwiecien J, Polanska J, Rewers M.
36J Oral Pathol Med. 2014 Sep;43(8):576-8. doi: 10.1111/jop.12194. Epub 2014 Apr 25.【摘要】
No evidence for Helicobacter pylori in oral lichen planus.
无证据显示口腔扁平苔藓与幽门螺杆菌相关
Hulimavu SR1, Mohanty L, V Tondikulam N, Shenoy S, Jamadar S, Bhadranna A.
37J Gastroenterol Hepatol. 2014 Sep;29(9):1671-7. doi: 10.1111/jgh.12605.【摘要】
Characteristics of gastric cancer according to Helicobacter pylori infection status.
根据幽门螺杆菌感染状态区分胃癌的临床特点
将胃癌根据幽门螺杆菌现症感染、既往感染、幽门螺杆菌阴性进行分类并探讨其临床特点，幽门螺杆菌阴性组胃癌更倾向与年轻、女性、弥漫性胃癌，比既往感染组出现远处转移的几率更高
Kwak HW1, Choi IJ, Cho SJ, Lee JY, Kim CG, Kook MC, Ryu KW, Kim YW.
38Curr Microbiol. 2014 Sep;69(3):245-51. doi: 10.1007/s00284-014-0578-8. Epub 2014 Apr 9.【摘要】
Helicobacter pylori identification: a diagnostic/confirmatory method for evaluation.
幽门螺杆菌鉴定：一种诊断/确认方法PCR-RFLP，能够将准确性从26.2%提高到42.6%
Mesquita B1, Gonçalves MJ, Pacheco P, Lopes J, Salazar F, Relvas M, Coelho C, Pacheco JJ, Velazco C.
39Proteins. 2014 Sep;82(9):2275-81. doi: 10.1002/prot.24572. Epub 2014 Apr 16.【摘要】
Crystal structure of JHP933 from Helicobacter pylori J99 shows two-domain architecture with a DUF1814 family nucleotidyltransferase domain and a helical bundle domain.
幽门螺杆菌J99的JHP933水晶结构显示为两个主要的结构域：DUF1814家族核苷酸转移酶结构域和螺旋束域
Yoon JY1, Lee SJ, Kim do J, Lee BJ, Yang JK, Suh SW.
40Dis Esophagus. 2014 Sep-Oct;27(7):645-53. doi: 10.1111/dote.12194. Epub 2014 Mar 17.【摘要】
Association of Helicobacter pylori infection with esophageal adenocarcinoma and squamous cell carcinoma: a meta-analysis.
幽门螺杆菌感染与食管腺癌与食管鳞状细胞癌的关系：meta分析
Nie S1, Chen T, Yang X, Huai P, Lu M.
41J Infect Dis. 2014 Sep 15;210(6):954-63. doi: 10.1093/infdis/jiu154. Epub 2014 Mar 12.【全文】
A role for the vacuolating cytotoxin, VacA, in colonization and Helicobacter pylori-induced metaplasia in the stomach.
VacA对胃内幽门螺杆菌定植和诱导化生的影响
Winter JA1, Letley DP1, Cook KW1, Rhead JL1, Zaitoun AA2, Ingram RJ1, Amilon KR1, Croxall NJ1, Kaye PV2, Robinson K1, Atherton JC1.
42Rev Med Interne. 2014 Sep;35(9):561-4. doi: 10.1016/j.revmed.2014.01.009. Epub 2014 Mar 4.【摘要】
[Helicobacter pylori 30 years after: What's new?].
发现幽门螺杆菌30年以后：有哪些新的进展：
[Article in French]
de Korwin JD.
43Clin Gastroenterol Hepatol. 2014 Sep;12(9):1578. doi: 10.1016/j.cgh.2014.02.029. Epub 2014 Feb 25.【摘要】
How can we rationally select Helicobacter pylori therapy without resistance data?
无抗生素耐药数据的时候如何合理选择幽门螺杆菌治疗方案
Moss SF.
44Int J Cancer. 2014 Sep 1;135(5):1127-31. doi: 10.1002/ijc.28758. Epub 2014 Feb 11.【摘要】
Helicobacter pylori but not gastrin is associated with the development of colonic neoplasms.
幽门螺杆菌，而不是胃泌素，与结肠肿瘤相关
Selgrad M1, Bornschein J, Kandulski A, Hille C, Weigt J, Roessner A, Wex T, Malfertheiner P.
45Gut. 2014 Sep;63(9):1410-5. doi: 10.1136/gutjnl-2013-306120. Epub 2013 Dec 2.【摘要】
Ten day sequential versus 10 day modified bismuth quadruple therapy as empirical firstline and secondline treatment for Helicobacter pylori in Chinese patients: an open label, randomised, crossover trial.
10天序贯疗法与10天改良含铋剂四联疗法作为中国人群幽门螺杆菌根除治疗的一线和二线方案：开放、随机、交叉实验
Liu KS, Hung IF, Seto WK, Tong T, Hsu AS, Lam FY, But DY, Wong SY, Leung WK.
{jcomments on}